Skip to main content

Closed

VBIO: Valion Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-141.9%

ROIC-2.1%

Financially safe

Strong

Debt / equity0.02×

Interest coverage33.1×

Current ratio0.57×

Valion Bio, Inc.

VBIONASDAQ·USD·Closed

Valion Bio, Inc.

VBIONASDAQ·USD·Closed

$0.31

+11.51%

$0.31

+$0.03 (11.51%)

52W Range

1thpctl

Volume

6.87×avg

Mkt Cap

992303USD

P/E

-10.3TTM

Div Yield

–ann

52W Range

1thpctl

Volume

6.87×avg

Market Cap

992303USD

P/E Ratio

-10.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings